Forward Therapeutics is a Palm Beach Gardens, Florida-based biopharmaceutical company developing next-generation small-molecule immune therapies for chronic inflammatory and immunological disorders. The company is advancing a pipeline of novel small-molecule immunology medicines and intends to use new capital to move programs toward clinical development. Forward raised $50M in a Series A financing to fund that progression. The Series A was led by BVF Partners with participation from RA Capital Management and OrbiMed. Forward Therapeutics has partnered with Curie.Bio, a new model for venture capital in biotech focused on helping founders launch therapeutics companies. The company is led by CEO Toufike Kanouni and CSO Ewan Taylor.

Total raised

$50M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2023